Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSheikh Zayed Federal Postgraduate Medical Institute

About this trial

The goal of this pilot randomized controlled trial is to compare pain relief efficacy while using nasal packing versus greater palatine foramen block (GPFB) in the management of acute episodes of epistaxis. The main questions it aims to answer are: Does GPFB have less potential to inflict pain when dealing with hemostasis with epistaxis, utilizing a pre-validated 10-point visual analog scale (VAS)? Was hemostasis management more effective in either technique? Researchers will compare anterior nasal packing to greater palatine foramen block using 2% xylocaine with adrenaline.

Patients will receive any of the hemostatic interventions at the time of the acute epistaxis episode.

The questionnaire will be administered 24 hours post-intervention.

Eligibility criteria

Qualifiers

Presentation with active anterior epistaxis

Failure of initial conservative measures (e.g., nasal compression and topical vasoconstrictors)

Ability to provide informed consent and those who consent for the study.

Disqualifiers

Suspected or confirmed posterior epistaxis

Known bleeding disorders or platelet count <50,000/mm³

Use of anticoagulants with supratherapeutic INR

Known allergy to local anaesthetic agents

Trial design

Treatments tested in this trial

  • Greater Palatine Foramen Block with 2% xylocaine with adrenaline
  • Anterior Nasal Packing

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations